Isoform selective PI3 kinase inhibitors for cancer, thrombosis and inflammatory disease

  • Thompson, Phillip, (Primary Chief Investigator (PCI))

Project: Research

StatusFinished
Effective start/end date1/01/1531/12/16

Funding

  • National Health & Medical Research Council (NHMRC): AUD462,809.20